CMS Statement on Drug Misclassification and Program Integrity Updates
2026 executive update · CMS drug misclassification audit · Leadership action CMS Statement on Drug Misclassification and Program Integrity Updates CMS policy on drug misclassification has moved from proposal to an enforceable operating frame..
- Posted by Greg Wahlstrom, MBA, HCM
- Posted in
CMS Roundup: May 3, 2024
2026 executive update · CMS policy implementation playbook · Leadership action CMS Roundup: May 3, 2024 The May 3, 2024 CMS Roundup brought together policy developments that touched very different operating areas: a MassHealth Section 1115 d..
- Posted by Greg Wahlstrom, MBA, HCM
- Posted in
Interoperable Exchange of Patient Health Information Among U.S. Hospitals in 2023
2026 executive update · hospital interoperability patient access · Leadership action Interoperable Exchange of Patient Health Information Among U.S. Hospitals in 2023 ONC’s 2023 hospital interoperability data showed meaningful progress..
- Posted by Greg Wahlstrom, MBA, HCM
- Posted in
CMS Roundup: May 3, 2024
2026 executive update · CMS board policy briefing · Leadership action CMS Roundup: May 3, 2024 The CMS Roundup issued May 3, 2024 combined developments in Medicaid coverage, health related social needs, Medicare coverage evidence, reentry ac..
- Posted by Greg Wahlstrom, MBA, HCM
- Posted in
CMS Statement on Drug Misclassification and Program Integrity Updates
2026 executive update · CMS drug reimbursement compliance · Leadership action CMS Statement on Drug Misclassification and Program Integrity Updates The CMS discussion of Medicaid drug misclassification developed into a final rule in Septembe..
- Posted by Greg Wahlstrom, MBA, HCM
- Posted in
Harnessing the Power of Mobile Health Applications to Improve Patient Compliance in 2024
2026 executive update · mobile health applications patient compliance · Leadership action Harnessing the Power of Mobile Health Applications to Improve Patient Compliance in 2024 Mobile health applications can support medication use, symptom..
- Posted by Greg Wahlstrom, MBA, HCM
- Posted in
Ethical Considerations in Biomedical Research and Patient Data Usage in 2024
2026 executive update · biomedical research ethics 2024 · Leadership action Ethical Considerations in Biomedical Research and Patient Data Usage in 2024 Biomedical research increasingly depends on information created during care, collected t..
- Posted by Greg Wahlstrom, MBA, HCM
- Posted in
Tackling Antibiotic Resistance: New Policies and Practices for 2024
2026 executive update · tackling antibiotic resistance 2024 · Leadership action Tackling Antibiotic Resistance: New Policies and Practices for 2024 Antimicrobial resistance develops when germs no longer respond to medicines designed to contr..
- Posted by Greg Wahlstrom, MBA, HCM
- Posted in
Healthcare Facility Design: Creating Healing Environments through Architecture in 2024
2026 executive update · healing environment architecture 2024 · Leadership action Healthcare Facility Design: Creating Healing Environments through Architecture in 2024 A healing environment is not a visual style. It is a care setting that s..
- Posted by Greg Wahlstrom, MBA, HCM
- Posted in
Developing Community Health Programs to Address Social Determinants of Health in 2024
2026 executive update · community health programs social determinants 2024 · Leadership action Developing Community Health Programs to Address Social Determinants of Health in 2024 Health is shaped by conditions in which people are born, liv..
- Posted by Greg Wahlstrom, MBA, HCM
- Posted in
